市場調査レポート
商品コード
1386408
前臨床In-Vivoイメージング市場レポート:2030年までの動向、予測、競合分析Preclinical In-Vivo Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
前臨床In-Vivoイメージング市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
前臨床In-Vivoイメージングの動向と予測
世界の前臨床in-vivoイメージング市場は、2024年から2030年までのCAGRが6.2%で、2030年までに推定14億米ドルに達すると予測されています。この市場の主な促進要因は、慢性疾患の有病率の増加、オン侵襲的小動物イメージング技術に対する需要の高まり、前臨床研究活動に対する資金提供の増加です。世界の前臨床in-vivoイメージング市場の将来は、研究開発と創薬市場における機会で有望視されています。
前臨床In-Vivoイメージング市場の洞察
Lucintelは、マイクロ超音波システムが予測期間中に最も高い成長を遂げると予測しています。
同市場では、研究開発や創薬へのモダリティの採用が増加していることから、研究開発が引き続き最大セグメントとなります。
北米は、前臨床研究量の増加とカナダにおける研究・技術革新に対する政府資金の増加により、引き続き最大地域となります。
Preclinical In-Vivo Imaging Trends and Forecast
The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.
A more than 150-page report is developed to help in your business decisions.
Preclinical In-Vivo Imaging by Segment
The study includes a forecast for the global preclinical in-vivo imaging by type, modality, application, distribution channel, and region.
Preclinical In-Vivo Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Preclinical In-Vivo Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:
Preclinical In-Vivo Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Preclinical In-Vivo Imaging Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
Preclinical In-Vivo Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Preclinical In-Vivo Imaging Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preclinical in-vivo imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-
Preclinical In-Vivo Imaging Market Insights
Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.
Within this market, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.
North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.
Features of the Global Preclinical In-Vivo Imaging Market
Market Size Estimates: Preclinical in-vivo imaging market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel and region in terms of ($B).
Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preclinical in-vivo imaging market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the preclinical in-vivo imaging market size?
Answer: The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030.
Q.2 What is the growth forecast for preclinical in-vivo imaging market?
Answer: The global preclinical in-vivo imaging market is expected to grow with a CAGR of 6.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the preclinical in-vivo imaging market?
Answer: The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.
Q4. What are the major segments for preclinical in-vivo imaging market?
Answer: The future of the preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets.
Q5. Who are the key preclinical in-vivo imaging market companies?
Answer: Some of the key preclinical in-vivo imaging companies are as follows:
Q6. Which preclinical in-vivo imaging market segment will be the largest in future?
Answer: Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.
Q7. In preclinical in-vivo imaging market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.